On the 23rd of April, Iceland, Denmark and Norway signed a cooperation agreement in an effort to lower drug prices for the public.
As reported in The Iceland Review reports, María Heimisdóttir, CEO of Icelandic Health Insurance (IHI) said:
“We firmly expect that purchasing in larger quantities with our neighbouring countries could reduce drug shortages and thus increase patient safety and that’s of course the most important thing.”
Health Minister for Iceland, Svandís Svavarsdóttir welcomed the long-awaited agreement coming into fruition. Speaking on the collaboration, Svavarsdóttir was hopeful the collaboration could place the three countries in a stronger position to negotiate lower pricing on particular drugs.
MAP will be closely following further developments.